Bold Insight and The Office of Experience partner to deliver outstanding user experiences.
Back to team page
Leigh Clark
Senior UX Researcher
Leigh has 10 years’ experience in user research with emerging technologies. He has a leading expertise in voice and text systems and is co-founder of the ACM Conversational User Interfaces (CUI) conference series. Leigh has published extensively and organised conferences and workshops in this area. His recent work examines how to design voice interfaces to make them more inclusive. As an industry advisor to the Open Voice Network, he continues to work with global researchers to design ethical voice interface guidelines. Leigh holds a PhD in Computer Science from the University of Nottingham and is a Visiting Lecturer at University College Dublin.
Bold facts
Learn more about
Something unique about you summed up in one sentence:
Your favorite city in the world is...and why?
In your spare time (or if you had spare time), you would absolutely do this:
Your ultimate celebrity dinner party guest list would include...
You cannot start the day without doing this...
What would be your most valuable zombie apocalypse skill?
Favorite TV show:
Share an interesting fact:
Read our team’s latest bold insights
When designing an experience, are you really thinking about the customer first?
While every organization has constraints to consider when designing experiences for customers or users, designing the ideal customer experience is completely possible within those constraints. Begin by identifying the experience you want your customer to have and work “backward” from there.
UX project logistics: choosing the right vendors for project success
Selecting the correct vendors to support your UX project is critical to success. From facilities to recruiting, knowing the right questions to ask, budget constraints, and client needs and expectations will make the selection process smooth and painless.
Reclassifying diabetes: 3 implications for product design
Recent research suggests that reclassifying diabetes may allow for the development of more targeted diabetes treatments. This could present opportunities to design these treatments to maximize patient safety and experience.